Concepedia

Goss S. Kauffman

GS

Statistics

Publications

13

Citations

682

H-Index

13

Active since

1984

Affiliations

DuPont (United States)(Current)

Pfizer (United States)

Forma Therapeutics (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Goss S. Kauffman is an author at DuPont (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

1984–2019

13

Publications

13

An Efficient Chiral Moderator Prepared from Inexpensive (+)-3-Carene:  Synthesis of the HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor DPC 963

Goss S. Kauffman, Gregory D. Harris, Roberta L. Dorow et al. · Organic Letters · 2000 · 193 citations

, , +11

Rearrangement of N<sub>α</sub>-Protected <scp>l</scp>-Asparagines with Iodosobenzene Diacetate. A Practical Route to β-Amino-<scp>l</scp>-alanine Derivatives

Linhua Zhang, Goss S. Kauffman, Jaan A. Pesti et al. · The Journal of Organic Chemistry · 1997 · 100 citations

, , +3

Synthesis and structure based optimization of novel Akt inhibitors

Blaise Lippa, Gonghua Pan, Matthew S. Corbett et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 76 citations · Full text

, , +12

Synthesis of Thrombin Inhibitor DuP 714

John Wityak, Richard A. Earl, Matthew M. Abelman et al. · The Journal of Organic Chemistry · 1995 · 75 citations

, , +14

Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors

Jian Lin, Wei Lu, Justin A. Caravella et al. · Journal of Medicinal Chemistry · 2019 · 47 citations · Full text

, , +15

1–5 of 13